July 2022 Price Hikes Report
In The Third Year Of The Pandemic And As Americans Grapple With Record Inflation, Big Pharma Continues To Raise Prices And Exploit Patients
In The Third Year Of The Pandemic And As Americans Grapple With Record Inflation, Big Pharma Continues To Raise Prices And Exploit Patients
Methodology and Dataset for July 2022 Price Hikes Report
My name is Emily. I’m a 26-year-old from Washington, D.C., and I live with psoriatic arthritis.
A new report issued today documents how drug companies use their market and political power to avoid competition and raise prices in lockstep.
This report examines the practices of BMS/Pfizer and Johnson & Johnson's lockstep price hikes and patent gaming on two blockbuster blood thinners and the implications for patients and taxpayers.
Since P4AD’s initial report in mid-January, drug companies have increased the price of 188 more drugs, bringing the total to 742 hikes so far this year.
Drug companies raised the prices of 742 drugs in January 2022
Methodology and Dataset for January Price Hikes 2.0 Report
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.